- GE-Forge collaboration provides turnkey equipment, installation and servicing solution for customers
- Combines GE's global equipment expertise with Forge Group's installation and servicing capabilities
GE's Industrial Solutions business today announced it had entered an agreement with Forge Group Ltd (ASX:FGE) to better meet the demand for engineered electrical solutions in Australia.
business unit
tags
MILWAUKEE - GE Healthcare announced today that its Discovery* PET/CT 690 and PET VCAR 2.0 were used by Professor Patrick Flamen of the Institut Jules Bordet in Brussels in capturing the Society of Nuclear Medicine and Molecular Imaging 2013 "Image of the Year."
Professor Flamen's winning scan illustrated the effectiveness of radium-223 dichloride in treating bone metastases in breast cancer patients with bone-dominant disease. It was selected as the winning image from more than 2,000 studies.
business unit
tags
WAUKESHA, WI -- July 30, 2013-- GE Healthcare, a unit of General Electric Company (NYSE:GE), announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the final module of its premarket approval application (PMA[1]) for GE Breast Tomosynthesis, an option of the Senographe* Essential system.
business unit
tags
GE Capital today announced that it had provided QEnergy, a leading Australian electricity retailer for small to medium-sized businesses (SMEs), with a $10 million financing facility.
The facility, which will increase in line with anticipated growth in the business, will help QEnergy expand its major operations in Queensland and New South Wales into Victoria, as well as continuing to grow in South Australia and the Northern Territory.
business unit
tags
Eurofins Scientific (EUFI.PA), the world leader in food, environment and pharmaceutical products testing, has signed an agreement with GE Healthcare for the exclusive right to offer GE Healthcare's Cytiva™ Cardiomyocytes for drug discovery and early development cardio toxicity screening services.
business unit
tags
GE has consistently supported the Renewable Energy Target (RET) of 45,000GWh by 2020 and welcomed the bipartisan support for the target.
As a supplier of more than 20,000 wind turbines around the world and a significant investor in renewable energy projects itself, GE believes a stable RET and favourable sites augured well for the future development of renewables as part of Australia's energy mix.
However, the current legislated requirement for the RET to reviewed every two years itself creates uncertainty for renewable energy project developers, investors and suppliers.